The U.S. government may restrict funding for research that uses human fetal tissue. The move would undermine medical science and prolong patients' suffering from devastating diseases. When you ...
Caris Life Sciences stands out for its broad molecular and AI-driven cancer diagnostics but faces upcoming volatility as the IPO lock-up expires on 15 December 2025. CAI's revenue growth is robust, ...
Caris GPSai™ utilizes deep learning to significantly improve diagnostic accuracy for cancers of unknown primary and misclassified tumors IRVING, Texas, Aug. 5, 2025 /PRNewswire/ -- Caris Life ...
Researchers from Lund University (Sweden) have investigated the tumor immune microenvironment of primary triple-negative breast cancer using digital image analysis of IHC-stained immune cells. To do ...